GALAXY deliverables Here you can get access to all the submitted GALAXY deliverables that are publically available. GALAXY Public Deliverables D1.1 Included first 300 (75%) patients in GALA-ALD Deliverable 1.1 report D1.2 Identified and included 100 healthy controls in GALA HP Deliverable 1.2 report D1.3 Included, treated and evaluated 136 patients in GAB-ALD D1.3 report D1.6 Approvals obtained for SYN-ALD D1.6 report D1.7 Identified and included 40 patients in SYN-ALD D1.7 report D1.8 Treated and evaluated patients in SYN-ALD D1.8 Report D4.2 Tool developed for integrative metagenomics-based metatranscriptomics data analysis D4.2 Report D7.4 Results disseminated: Submitted article to an international journal on the costs and benefits of the treatments, made final results available online, co-organised conference to disseminate results D7.4 report D8.1 Project infrastructure established D8.1 Report D8.2 Collaborative website ready to use D8.2 Report D8.3 Data management plan D8.3 Report D8.4 Exploitation plan and updates D8.4 Report D8.5 Future exploitation strategy described D8.5 Report D1.1 Included first 300 patients in the cohort study GALA-ALD: Gut-and-liver axis in alcoholic liver fibrosis (M0-12) (OUH) Link to report D1.2 Identified and included 100 healthy controls in GALA-HP: Gut-and-liver axis in a healthy population Link to report D4.2 Tool developed for integrative metagenomics-based metatranscriptomics data analysis Link to report D8.1 Project infrastructure established Link to report D8.2 Collaborative website Link to report D8.3 Initial Data Management Plan Link to report D8.5 Future Exploitation Strategy Described Link to report Share on Facebook Twitter Linkedin Email
